- Home
- ZLAB vs MC Comparison
ZLAB vs MC Comparison
Compare ZLAB & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- MC
- Stock Information
- Founded
- ZLAB 2013
- MC 2007
- Country
- ZLAB China
- MC United States
- Employees
- ZLAB N/A
- MC N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- MC Investment Managers
- Sector
- ZLAB Health Care
- MC Finance
- Exchange
- ZLAB Nasdaq
- MC Nasdaq
- Market Cap
- ZLAB 3.5B
- MC 3.6B
- IPO Year
- ZLAB 2017
- MC 2014
- Fundamental
- Price
- ZLAB $29.24
- MC $54.93
- Analyst Decision
- ZLAB Buy
- MC Hold
- Analyst Count
- ZLAB 4
- MC 7
- Target Price
- ZLAB $47.37
- MC $61.83
- AVG Volume (30 Days)
- ZLAB 1.2M
- MC 1.0M
- Earning Date
- ZLAB 05-08-2025
- MC 04-23-2025
- Dividend Yield
- ZLAB N/A
- MC 4.73%
- EPS Growth
- ZLAB N/A
- MC N/A
- EPS
- ZLAB N/A
- MC 2.29
- Revenue
- ZLAB $418,326,000.00
- MC $1,283,653,000.00
- Revenue This Year
- ZLAB $44.43
- MC $15.19
- Revenue Next Year
- ZLAB $48.68
- MC $16.57
- P/E Ratio
- ZLAB N/A
- MC $24.02
- Revenue Growth
- ZLAB 43.72
- MC 45.14
- 52 Week Low
- ZLAB $15.65
- MC $47.00
- 52 Week High
- ZLAB $39.77
- MC $82.89
- Technical
- Relative Strength Index (RSI)
- ZLAB 42.71
- MC 51.93
- Support Level
- ZLAB $27.61
- MC $51.98
- Resistance Level
- ZLAB $32.02
- MC $55.50
- Average True Range (ATR)
- ZLAB 1.23
- MC 1.73
- MACD
- ZLAB -0.18
- MC 0.68
- Stochastic Oscillator
- ZLAB 23.41
- MC 88.19
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About MC Moelis & Company
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.